Neonc Technologies Holdings, Inc. (NASDAQ:NTHI – Get Free Report)’s share price dropped 15.7% on Tuesday . The company traded as low as $10.10 and last traded at $11.26. Approximately 39,700 shares traded hands during trading, a decline of 11% from the average daily volume of 44,725 shares. The stock had previously closed at $13.36.
Neonc Technologies Trading Down 15.7 %
About Neonc Technologies
Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing.
Further Reading
- Five stocks we like better than Neonc Technologies
- Why Invest in 5G? How to Invest in 5G Stocks
- Boeing Stock Upgraded After Beating Lockheed for Jet Deal
- What is the Nasdaq? Complete Overview with History
- 2 Reasons to Buy Apple Stock and 1 Significant Risk
- What is the Australian Securities Exchange (ASX)
- Salesforce: The Most Resilient Software Stock for Downturns
Receive News & Ratings for Neonc Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neonc Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
